Clinical trial
Randomized Factorial Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention to Promote Smoking Cessation
NCT07099638 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Factorial Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention to Promote Smoking Cessation
- Lead sponsor
- University of Oklahoma
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- July 21, 2026
- Completion date
- June 1, 2029
- Enrollment
- 496 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
smoking cessation